Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 1997

View Archived Issues

Scios licenses BNP technology to Abbott

Trega Biosciences and Chiroscience collaborate on cell adhesion inhibitors

U. of California discloses mammalian EPO-BP

Anti E- and P-selectin antibodies from PDL

NEP/ACE/ECE inhibitors described by Wakamoto

NeoRx reaches milestone in Biostent development

Preclinical and clinical data support use of cerebrocrast as neuroprotectant

State University of New York grants license to Noven for anticavity compounds

Shaman issued U.S. patents for type II diabetes compounds

Update on HIV research at Sheffield

Shire & Janssen acquire rights to Nivalin

Banyu developing new anticancer agent

New C5a antagonist discovered by Rhone-Poulenc Rorer

Dura signs collaboration agreements for Spiros inhalation system

Bristol-Myers Squibb selects diacid for development as antipsoriatic

Dual H1 and CysLT1 antagonist reported by Dutch and Japanese researchers

New analgesic under development by BioChem Pharma and Astra

New series for dementia from SIBIA Neurosciences

New MRI contrast agent from Nycomed

Basiliximab clinical data presented

Protein tyrosine kinase inhibition as antirejection therapy

Anti-TAC antibody prevents transplant rejection in phase III

Newly established Millennium BioTherapeutics enters therapeutic protein development collaboration

Mechanism of antiproliferative activity of SP-100030 defined

Dietary amino acids enhance allograft survival in rats

IL-10 pretreatment of transplant recipients prolongs allograft survival

Matrix Pharmaceutical's AccuSite recommended for approval in six European countries

Immunomedics' antibody therapy for non-Hodgkin's lymphoma shows promise in clinical trial

Genzyme and LeukoSite collaborate on autoimmune and inflammatory disease therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...